Monitoring Agency Report for the quarter ended December 31, 2025.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has filed its Monitoring Agency Report for the third quarter of FY26 (October–December 2025) with the stock exchanges. Under SEBI rules, companies that raise money through a public issue, rights issue, or preferential allotment must appoint an independent monitoring agency to track how those funds are being spent. This report confirms that the company has complied with that requirement and submitted the quarterly update on utilization of the proceeds. Such reports continue to be filed until the entire amount raised is fully deployed for the stated purpose.
This is a routine compliance filing and is unlikely to move the stock on its own. However, the underlying report may reveal whether the company is deploying the raised funds on schedule or diverting them, which investors can review for any deviations from the original plan.